Enjoy complimentary customisation on priority with our Enterprise License!
The continuous renal replacement therapy devices market size is forecast to increase by USD 611.31 million at a CAGR of 8.07% between 2023 and 2028. Continuous Renal Replacement Therapy (CRRT) devices have gained significant traction in the healthcare industry due to their clinical advantages in managing kidney-related diseases, particularly in cases of fluid overload, sepsis, and congestive heart failure. The market for these devices is driven by the increasing prevalence of acute renal failure and the need for effective fluid management in hospitalized patients. Moreover, anticoagulants used for blood infusion during CRRT operations are not approved by the FDA, despite their usage. CRRT offers several advantages over Intermittent Renal Replacement Therapy (IRRT), including improved acid-base balance and the ability to use lactate-buffered solutions for convection and diffusion. However, the market faces challenges due to stringent regulatory guidelines in North America, which necessitate the use of disposables and high-quality replacement fluids to ensure patient safety. The opportunities in emerging markets, where the incidence of kidney-related diseases is on the rise, offer significant growth potential for CRRT device manufacturers.
The market is witnessing significant growth due to the increasing prevalence of acute kidney injury (AKI) and the rising number of intensive care unit (ICU) admissions. These therapies play a crucial role in managing uremic toxins and maintaining hemodynamic stability in critically ill patients, particularly those suffering from heart disease, stroke, and hypertension. CRRT devices are essential in the ICU setting for managing hemodynamic instability and electrolyte imbalances in patients with AKI. These devices employ various technologies such as hemofiltration, hemodiafiltration, and hemodialysis to remove toxins and maintain fluid balance.
Moreover, membrane technology plays a pivotal role in the efficient removal of solutes and preserving the integrity of the patient's blood components. Automated prescription and analytics have revolutionized the CRRT market by enabling personalized treatment plans for individual patients. These innovative products have streamlined medical interventions and improved patient outcomes. Catheters and filters are essential components of CRRT systems, and advancements in their design and functionality have enhanced their efficiency and durability. The geriatric population is a significant consumer of CRRT devices due to their increased susceptibility to kidney diseases and comorbidities. Regulatory guidelines ensure the approval of safe and effective CRRT systems and consumables, ensuring the highest quality metrics are maintained.
Furthermore, technological advancements continue to shape the CRRT market, with continuous venovenous hemodiafiltration (CVVHDF) emerging as a preferred modality due to its ability to provide efficient solute removal and fluid management. Intermittent hemodialysis (IHD) still holds a significant market share but is gradually being replaced by CRRT due to its limitations in managing hemodynamic instability and providing adequate fluid removal. The ICU setting is the primary market for CRRT devices, and their usage is expected to increase as the number of critically ill patients continues to rise. The market is highly competitive, with various players offering a range of products and services. However, the focus on technological advancements and regulatory compliance will remain the key drivers of growth in the CRRT devices market.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The consumables segment is estimated to witness significant growth during the forecast period.In the healthcare industry, Continuous Renal Replacement Therapy (CRRT) devices have gained significant traction due to their ability to provide intermittent blood purification for critically ill patients, particularly those in Intensive Care Units (ICUs) within the adult population. These technologically advanced systems consist of a machine and its consumables, which include an artificial semipermeable membrane, an extracorporeal circuit, and therapy fluids such as dialysates and replacement fluids. The artificial semipermeable membrane is a crucial component that facilitates solute and water removal while correcting electrolyte abnormalities and acid-base disturbances.
Furthermore, the constant demand for consumables due to their one-time use contributes to the revenue growth in this segment. Hospitals are the primary end-users of CRRT devices, with cross-institutional purchases being common due to the large and growing patient base of End-Stage Renal Disease (ESRD) patients. Regulatory barriers, including the need for sterilized bicarbonate-buffered solutions and stringent quality standards, pose challenges to market growth. However, the increasing purchasing power of hospitals and the availability of uniform language and guidelines for CRRT therapy are expected to offset these challenges.
Get a glance at the market share of various segments Request Free Sample
The consumables segment accounted for USD 701.62 million in 2018 and showed a gradual increase during the forecast period.
Europe is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market is experiencing significant growth due to several factors. The aging population in Europe is a major driver, as an increasing number of critically ill patients require advanced renal replacement therapies, such as CRRT, to manage Acute Kidney Injury (AKI). New product launches and technological advancements, including automated prescription and improved membrane technology, are also contributing to market expansion. Heart disease and stroke patients are significant user groups for CRRT devices, as they often require long-term renal support. Europe's leadership in medical research and innovation is further fueling market growth. Ongoing clinical trials and studies are focused on enhancing CRRT outcomes, optimizing therapy delivery, and developing novel technologies.
Furthermore, automated prescription systems and innovative catheter and filter designs are under development to streamline CRRT administration and improve patient care. The increasing prevalence of diabetes in Europe is another critical factor influencing the market. Diabetes is a leading cause of AKI, and the growing number of patients with diabetes who require RRT poses a significant challenge to healthcare systems, particularly in developing countries like Nigeria. Despite these challenges, the market for CRRT devices in Europe is expected to continue growing, driven by the increasing demand for advanced renal replacement therapies and the ongoing research and development efforts in the region.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The advantages of CRRT over IRRT is the key driver of the market. Continuous Renal Replacement Therapy (CRRT) devices have gained significant attention in the intensive care unit (ICU) setting for critically ill patients with acute kidney injury (AKI) or kidney-related diseases. CRRT provides clinical advantages over intermittent blood purification techniques such as intermittent hemodialysis (IHD), sustained low-efficiency daily dialysis (SLEDD), and peritoneal dialysis (PD). CRRT offers more hemodynamic stability, enabling appropriate fluid clearance, faster recovery of renal function, and efficient removal of small and large metabolites. This makes CRRT a preferred choice for medical practitioners in the ICU, leading to increased market demand. CRRT improves the renal system by continuously and gently removing excess metabolic waste products while maintaining normal electrolyte and acid-base balance.
Technological advancements in CRRT devices include automated prescription, innovative products such as continuous venovenous hemodiafiltration (CVVHDF), and data analytics for quality metrics. These advancements cater to the needs of various patient populations, including heart disease, stroke, hypertension, geriatric population, and sepsis. Market dynamics are driven by factors like ICU admissions, regulatory approval, and clinical problems in adult and pediatric populations. Market players focus on producing technologically advanced CRRT machines, delivery patterns, and replacement fluids to cater to the evolving needs of hospitals and urgent care centers. Regulatory guidelines and quality assurance are essential for ensuring the safety and efficacy of CRRT devices. Such factors will increase the market growth during the forecast period.
Opportunities in emerging markets is the upcoming trend in the market. The Continuous Renal Replacement Therapy (CRRT) devices market is experiencing significant growth due to the increasing prevalence of critically ill patients, particularly those suffering from heart disease, stroke, and acute kidney injury (AKI). In the intensive care unit (ICU) setting, CRRT has become a preferred choice for managing uremic toxins, electrolyte imbalances, and hemodynamic instability in patients with severe renal diseases. CRRT technologies, such as continuous venovenous hemodiafiltration (CVVHDF), have gained clinical advantage over intermittent hemodialysis (IHD) due to their ability to deliver continuous medical interventions, including filtration, convection, and diffusion. Technological advancements in CRRT devices, including automated prescription, data analytics, and innovative products like sterilized bicarbonate-buffered solutions and lactate-buffered dialysates, have improved patient outcomes and clinical results.
The market is also driven by the growing ICU admissions, regulatory support, and approval of CRRT devices for various kidney-related diseases. The geriatric population, with its higher susceptibility to kidney diseases, is another significant market driver. CRRT devices are also gaining popularity in community hospitals and urgent care centers, expanding the market's reach beyond large, tertiary care hospitals. However, regulatory guidelines and purchasing power are key barriers to entry for new market players. The Asia Pacific region, with its large and growing population and high prevalence of AKI, presents significant growth opportunities for CRRT device manufacturers. China, India, and Mexico are among the emerging markets with the highest potential for CRRT device sales. Such factors will increase the market trends and analysis during the forecast period.
Stringent regulatory guidelines for CRRT devices in North America is a key challenge affecting the market growth. The market in North America is influenced by several regulatory barriers, which hinder the approval process for CRRT machines and medicines. The US Food and Drug Administration (FDA) imposes stringent regulations on CRRT products, making it challenging for manufacturers to gain approval for indications beyond acute kidney injury (AKI) and hemodynamic instability. In contrast, European countries approve CRRT for various indications, including liver support, increased intracranial pressure, intoxication, cardiac failure, tumor lysis syndrome, and post-cardiac surgery. However, no CRRT machine in North America has received FDA approval for these indications.
CRRT plays a crucial role in managing critically ill patients suffering from kidney-related diseases, heart disease, stroke, sepsis, and hypertension, particularly in the intensive care unit (ICU) setting. Technological advancements in CRRT, such as continuous venovenous hemodiafiltration (CVVHDF), have led to the development of innovative products like sterilized bicarbonate-buffered solutions, dialysates, and lactate-buffered solutions. The ICU population, including the geriatric population, benefits significantly from CRRT, which addresses issues like fluid overload, electrolyte imbalance, and acid-base balance. The market for CRRT devices includes systems, consumables, filters, catheters, and disposables, with key market players investing in automated data gathering for improved patient outcomes and quality assurance. Such factors will hinder the market analysis and report during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Ardia Digital Health Ltd. - The company offers continuous renal replacement therapy for patients that suffer from acute kidney failure, and are in an intensive care unit.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
In the Intensive Care Unit (ICU) setting, critically ill patients with heart disease, stroke, sepsis, acute kidney injury (AKI), and other kidney-related diseases require advanced renal replacement therapies. Continuous Renal Replacement Therapies (CRRT), including Continuous Veno-Venous Hemodiafiltration (CVVHDF), provide innovative solutions for managing uremic toxins, electrolytes, and acid-base balance in hemodynamically unstable patients. CRRT devices utilize advanced membrane technology and automated prescription to deliver personalized treatment in the ICU. These systems consist of filters, catheters, and replacement fluids, offering clinical advantages over intermittent hemodialysis. Technological advancements in CRRT include data analytics, which enable better patient outcomes and quality metrics.
Further, the integration of medical technology and artificial intelligence in healthcare is reshaping critical care medicine, offering advanced patient monitoring and remote patient monitoring solutions that significantly enhance health outcomes. With innovations in biomedical engineering, medical devices, and surgical interventions, healthcare professionals are improving the management of conditions like chronic kidney disease, renal injury, and acute care complications. Precision medicine and drug safety initiatives are key in pharmacovigilance efforts, ensuring optimal drug safety and personalized treatments. The rise of telemedicine and healthcare providers delivering care remotely are addressing challenges in rural hospitals, improving patient education, health literacy, and quality of life for individuals with long-term conditions. Moreover, hospital-acquired infections and complications are being minimized through advanced protocols, training programs, and medical supplies, while cost-effectiveness in treatments and FDA regulations continue to guide medical advancements. With healthcare technology on the rise, the medical device industry and biotechnology are setting the stage for improved prescription patterns and better care for pediatrics, adult systems, and those in home care settings.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
166 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.07% |
|
Market growth 2024-2028 |
USD 611.31 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.99 |
|
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
|
Performing market contribution |
Europe at 32% |
|
Key countries |
US, Germany, UK, China, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Ardia Digital Health Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., CytoSorbents Corp., DaVita Inc., DIAMED Medizintechnik GmbH, ECRI, Fresenius Medical Care AG and Co. KGaA, Infomed SA, Medica S.p.A., Medical Components Inc., Medtronic Plc, Nikkiso Co. Ltd., Nipro Medical Corp., SWS Hemodialysis Care Co. Ltd., Toray Industries Inc., Apollo Health and Lifestyle Ltd., Asahi Kasei Corp., and Medites Pharma spol. s.r.o. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
